Valuation China Resources Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 09:08:07 02/09/2026 BST			5-day change	1st Jan Change
4.410 ^HKD	-0.79%		-3.82%	-0.90%

09-01	China Resources Pharma Unit's Bond Program Registration Accepted in China	MT
08-24	China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,303	39,705	32,229	35,810	27,957	27,926	-	-
Change	-	78.03%	-18.83%	11.11%	-21.93%	-0.11%	-	-
Enterprise Value (EV) ¹	61,337	73,426	71,468	90,725	90,801	76,615	70,454	58,147
Change	-	19.71%	-2.67%	26.95%	0.08%	-15.62%	-8.04%	-17.47%
P/E	5.92x	9.58x	7.76x	10x	6.12x	5.72x	5.36x	5.15x
PBR	0.44x	0.8x	0.32x	0.34x	0.48x	0.43x	0.4x	0.36x
PEG	-	1x	44.15x	-0.7x	0.2x	0.82x	0.81x	1.22x
Capitalization / Revenue	0.09x	0.16x	0.12x	0.13x	0.09x	0.09x	0.08x	0.08x
EV / Revenue	0.26x	0.29x	0.27x	0.33x	0.3x	0.23x	0.21x	0.17x
EV / EBITDA	4.83x	4.38x	4.65x	5.47x	4.73x	3.81x	3.28x	2.81x
EV / EBIT	6.22x	5.39x	5.98x	6.98x	6.23x	4.87x	4.12x	3.45x
EV / FCF	5.88x	7.47x	5.49x	5.73x	4.37x	-28.2x	9.6x	6.45x
FCF Yield	17%	13.4%	18.2%	17.5%	22.9%	-3.55%	10.4%	15.5%
Dividend per Share ²	0.15	0.16	0.1669	0.1445	0.2203	0.2008	0.2169	0.182
Rate of return	4.23%	2.53%	3.25%	2.54%	4.95%	4.52%	4.88%	4.09%
EPS ²	0.6	0.66	0.6612	0.5677	0.7268	0.7775	0.829	0.8639
Distribution rate	25%	24.2%	25.2%	25.5%	30.3%	25.8%	26.2%	21.1%
Net sales ¹	236,806	254,106	265,229	275,999	306,131	328,114	340,766	352,363
EBITDA ¹	12,690	16,775	15,382	16,601	19,202	20,083	21,457	20,701
EBIT ¹	9,868	13,623	11,952	13,005	14,567	15,738	17,112	16,864
Net income ¹	3,769	4,147	4,178	3,589	4,594	4,797	5,157	5,309
Net Debt ¹	39,035	33,720	39,238	54,915	62,844	48,689	42,528	30,221
Reference price ²	3.550	6.320	5.130	5.700	4.450	4.445	4.445	4.445
Nbr of stocks (in thousands)	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	6,282,510	-	-
Announcement Date	29/03/22	30/03/23	26/03/24	26/03/25	24/03/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	5.72x	0.23x	3.81x	4.52%	3.56B
ELI LILLY AND COMPANY	33.02x	11.99x	24.3x	0.6%	1,034B
JOHNSON & JOHNSON	29.7x	-	-	1.98%	654B
ABBVIE INC.	33.18x	7.69x	15.99x	2.64%	459B
ROCHE HOLDING AG	19.36x	4.61x	11.42x	2.88%	343B
NOVARTIS AG	22.91x	5.89x	14.6x	2.71%	307B
ASTRAZENECA PLC	20.82x	4.27x	12.21x	2.06%	251B
AMGEN INC.	27.71x	7.15x	12.7x	2.3%	237B
NOVO NORDISK A/S	13.18x	4.74x	9.88x	3.82%	202B
GILEAD SCIENCES, INC.	-45.81x	6.6x	25.78x	2.2%	186B
Average	15.98x	5.91x	14.52x	2.57%	367.52B
Weighted average by Cap.	24.06x	8.03x	17.78x	1.96%